tiprankstipranks
Q BioMed Inc (QBIO)
OTHER OTC:QBIO
US Market

Q BioMed (QBIO) Stock Price & Analysis

101 Followers

QBIO Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range<$0.01 - $0.02
Previous Close$0.01
Volume500.00
Average Volume (3M)N/A
Market Cap
$145.00
Enterprise Value$4.06M
Total Cash (Recent Filing)$23.17K
Total Debt (Recent Filing)$4.08M
Price to Earnings (P/E)-0.2
Beta-33.44
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.07
Shares Outstanding145,094,531
10 Day Avg. Volume964
30 Day Avg. VolumeN/A
Standard Deviation51.52
R-Squared0.00668
Alpha5.68
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)0.05
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue19.40
Enterprise Value/Gross Profit-451.74
Enterprise Value/Ebitda-18.76
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Ownership Overview

2.47%0.00%<0.01%97.52%
2.47%
Insiders
0.00%
Mutual Funds
<0.01% Other Institutional Investors
97.52% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

QBIO FAQ

What was Q BioMed Inc’s price range in the past 12 months?
Q BioMed Inc lowest stock price was <$0.01 and its highest was $0.01 in the past 12 months.
    What is Q BioMed Inc’s market cap?
    Currently, no data Available
    When is Q BioMed Inc’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were Q BioMed Inc’s earnings last quarter?
    Currently, no data Available
    Is Q BioMed Inc overvalued?
    According to Wall Street analysts Q BioMed Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does Q BioMed Inc pay dividends?
      Q BioMed Inc does not currently pay dividends.
      What is Q BioMed Inc’s EPS estimate?
      Q BioMed Inc’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does Q BioMed Inc have?
      Q BioMed Inc has 145,094,530 shares outstanding.
        What happened to Q BioMed Inc’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of Q BioMed Inc?
        Currently, no hedge funds are holding shares in QBIO
        ---

        Q BioMed Stock Smart Score

        N/A
        Not Ranked
        1
        2
        3
        4
        5
        6
        7
        8
        9
        10

        Company Description

        Q BioMed Inc

        Q BioMed, Inc. operates as a biomedical acceleration and development company. It focuses on acquiring, licensing, and providing resources to life sciences and healthcare companies. Its products include Strontium 89, QBM-001, Uttroside-B, and MAN 01. The company was founded by Enrique Navas on November 22, 2013 and is headquartered in New York, NY.
        ---
        Similar Stocks
        Company
        Price & Change
        Follow
        Agile Therapeutics
        Fate Therapeutics
        Medicinova
        Traws Pharma
        Popular Stocks
        ---
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis